Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A novel approach for reliable detection of cathepsin S activities in mouse antigen presenting cells.
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina.
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
The New Era of Multiple Sclerosis Therapeutics.
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Progressive multiple sclerosis: pathology and pathogenesis.
Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence.
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
Diagnosis and differential diagnosis of multiple sclerosis.
Paroxysmal ataxia and dysarthria in multiple sclerosis.
A prospective cohort study of vitamin D in optic neuritis recovery.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
Treatment of multiple sclerosis in children and its challenges.
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
TCR Bias and HLA Cross-Restriction Are Strategies of Human Brain-Infiltrating JC Virus-Specific CD4+ T Cells during Viral Infection.
[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).

Pages